会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • In vitro differentiated cell and human embryonic stem cell population
    • 体外分化细胞和人胚胎干细胞群体
    • US08426198B2
    • 2013-04-23
    • US11359341
    • 2006-02-21
    • Joseph D. GoldJane S. Lebkowski
    • Joseph D. GoldJane S. Lebkowski
    • C12N5/071C12N15/00
    • C12N15/85A61K35/12C12N5/0606C12N2502/13C12N2510/00
    • This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gene to be expressed in relatively undifferentiated cells in the population. Expression of the effector gene results in depletion of undifferentiated cells, or expression of a marker that can be used to remove them later. Suitable effector sequences encode a toxin, a protein that induces apoptosis; a cell-surface antigen, or an enzyme (such as thymidine kinase) that converts a prodrug into a substance that is lethal to the cell. The differentiated cell populations produced according to this disclosure are suitable for use in tissue regeneration, and non-therapeutic applications such as drug screening.
    • 本发明提供了一种用于从干细胞群体产生分化细胞的系统,用于需要相对均匀细胞群体的地方。 细胞含有在转录控制元件(例如TERT启动子)的控制下的效应基因,其导致基因在群体中相对未分化的细胞中表达。 效应基因的表达导致未分化细胞的消耗或可以用于稍后去除它们的标记物的表达。 合适的效应序列编码毒素,诱导细胞凋亡的蛋白质; 细胞表面抗原或将前药转化为对细胞致死的物质的酶(例如胸苷激酶)。 根据本公开生产的分化细胞群体适用于组织再生和非治疗应用,例如药物筛选。